These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12789873)

  • 1. Stability of nifedipine in an extemporaneously compounded oral solution.
    Dentinger PJ; Swenson CF; Anaizi NH
    Am J Health Syst Pharm; 2003 May; 60(10):1019-22. PubMed ID: 12789873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of codeine phosphate in an extemporaneously compounded syrup.
    Dentinger PJ; Swenson CF
    Am J Health Syst Pharm; 2007 Dec; 64(24):2569-73. PubMed ID: 18056945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes.
    Walsh A; Ziegler B; Lingertat-Walsh K; Law S; Walker SE
    Int J Pharm Compd; 2021; 25(2):163-168. PubMed ID: 33798116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes.
    Dentinger PJ; Swenson CF
    Ann Pharmacother; 2009 Mar; 43(3):485-9. PubMed ID: 19208778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Extemporaneously Compounded Domperidone 5 mg/mL Suspension in Oral Mix in Plastic and Glass Bottles and Plastic Syringes.
    Lingertat-Walsh K; Law S; Walker SE
    Can J Hosp Pharm; 2018; 71(3):165-172. PubMed ID: 29955189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes.
    Huffman J; Brown S; Lewis P; Lawson S; Ogle A; Peacock G
    Int J Pharm Compd; 2018; 22(4):340-344. PubMed ID: 30021190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteral suspension of nifedipine for neonates. Part 2. Stability of an extemporaneously compounded nifedipine suspension.
    Helin-Tanninen M; Naaranlahti T; Kontra K; Ojanen T
    J Clin Pharm Ther; 2001 Feb; 26(1):59-66. PubMed ID: 11286608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups.
    Kirk L; Lewis P; Luu Y; Brown S
    Int J Pharm Compd; 2016; 20(2):159-63. PubMed ID: 27323427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of Extemporaneously Compounded Suspensions of Trimethoprim and Sulfamethoxazole in Amber Plastic Bottles and Amber Plastic Syringes.
    St-Jean I; Friciu MM; Monfort A; MacMahon J; Forest JM; Walker S; Leclair G
    Can J Hosp Pharm; 2021; 74(4):327-333. PubMed ID: 34602620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of melatonin in an extemporaneously compounded sublingual solution and hard gelatin capsule.
    Haywood A; Burrell A; Breda Kv; George R; Testa C; Norris R
    Int J Pharm Compd; 2009; 13(2):170-4. PubMed ID: 23970011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
    Boulton DW; Fawcett JP; Woods DJ
    Am J Health Syst Pharm; 1996 May; 53(10):1157-61. PubMed ID: 8734676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ; Johnson CE; Klein KC
    Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
    Cober MP; Johnson CE; Sudekum D; Penprase K
    Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of mycophenolate mofetil in an extemporaneously compounded oral liquid.
    Anaizi NH; Swenson CF; Dentinger PJ
    Am J Health Syst Pharm; 1998 May; 55(9):926-9. PubMed ID: 9588251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of tacrolimus in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; West NJ; Foster JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):178-80. PubMed ID: 9117806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of ampicillin trihydrate suspension in amber plastic oral syringes.
    Sylvestri MF; Makoid MC
    Am J Hosp Pharm; 1986 Jun; 43(6):1496-8. PubMed ID: 3728487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.